Azadi Amir, Kheirollahi Asma, Amidi Fardin, Jabarpour Masoome, Vatannejad Akram, Shabani Nashtaei Maryam, Moradi Nariman, Ansaripour Soheila
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
J Reprod Infertil. 2025 Jan-Mar;26(1):50-57. doi: 10.18502/jri.v26i1.18781.
Infertility and miscarriage are common complications in women with PCOS, and may be linked with metabolic status and thyroid function. However, the role of ANGPTL6 in PCOS-related infertility and miscarriage remains underexplored. Study assessed serum ANGPTL6 levels in Iranian PCOS patients and its association with miscarriage, infertility, and thyroid dysfunction.
This case-control study included 116 PCOS women (58 with infertility, 58 with a history of miscarriage) and 58 non-PCOS controls. The measurement of ANGPTL6, adiponectin, fasting insulin, and other hormonal parameters were measured using ELISA. Parametric data were analyzed with t-tests and ANOVA, and non-parametric data with Mann-Whitney and Kruskal-Wallis tests. Correlations were assessed using Pearson and Spearman tests. Logistic regression was used predicted PCOS risk. A p<0.05 was considered statistically significant.
ANGPTL6 levels were significantly higher in the PCOS group (48.72±21.41 ) and the PCOS-miscarriage subgroup (50.16±19.57 ) compared to the non-PCOS group (41.56±14.74 ). T4 levels were significantly lower in the PCOS group (2.5±1.9 ) compared to controls (3.9±4.6 , p<0.001). No significant correlation was found between ANGPTL6 and thyroid function tests. A positive correlation was observed between ANGPTL6 and adiponectin in the PCOS group (p<0.01). Logistic regression showed a significant association between ANGPTL6 and the risk of PCOS (OR: 1.02, 95%CI: 1.002-1.038), even after adjusting for age, body mass index (BMI), and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR).
Elevated ANGPTL6 levels were correlated with PCOS. Future research is needed to explore the molecular pathways linking ANGPTL6 to PCOS and its interaction with metabolic biomarkers.
不孕和流产是多囊卵巢综合征(PCOS)女性常见的并发症,可能与代谢状态和甲状腺功能有关。然而,血管生成素样蛋白6(ANGPTL6)在PCOS相关不孕和流产中的作用仍未得到充分研究。本研究评估了伊朗PCOS患者血清ANGPTL6水平及其与流产、不孕和甲状腺功能障碍的关系。
本病例对照研究纳入了116例PCOS女性(58例不孕,58例有流产史)和58例非PCOS对照。采用酶联免疫吸附测定法(ELISA)检测ANGPTL6、脂联素、空腹胰岛素及其他激素参数。参数数据采用t检验和方差分析,非参数数据采用曼-惠特尼检验和克鲁斯卡尔-沃利斯检验。采用Pearson和Spearman检验评估相关性。采用逻辑回归预测PCOS风险。p<0.05被认为具有统计学意义。
与非PCOS组(41.56±14.74)相比,PCOS组(48.72±21.41)和PCOS流产亚组(50.16±19.57)的ANGPTL6水平显著升高。与对照组(3.9±4.6,p<0.001)相比,PCOS组的T4水平显著降低(2.5±1.9)。未发现ANGPTL6与甲状腺功能检查之间存在显著相关性。PCOS组中ANGPTL6与脂联素呈正相关(p<0.01)。逻辑回归显示,即使在调整年龄、体重指数(BMI)和胰岛素抵抗稳态模型评估(HOMA-IR)后,ANGPTL6与PCOS风险之间仍存在显著关联(OR:1.02,95%CI:1.002-1.038)。
ANGPTL6水平升高与PCOS相关。未来需要进一步研究探索将ANGPTL6与PCOS联系起来的分子途径及其与代谢生物标志物的相互作用。